The vaccine is the first component of the Sputnik V drug, the first vaccine registered in the Eurasian nation to fight the Covid-19 pandemic.

According to the RDIF, immunization with the Russian vaccine will curb contagions in Armenia and accelerate the creation of population immunity in the country, where the use of Sputnik V was approved in February.

The RDIF assured that Sputnik Light shows high safety and efficacy rates in different countries. The example is the province of Buenos Aires, in Argentina, where efficacy in older people has reached 78.6 to 83.7 percent, while in Paraguay it was 93.5 percent.

jg/lcr/mem/mml/gdc